0001493152-18-011937.txt : 20180815 0001493152-18-011937.hdr.sgml : 20180815 20180814200330 ACCESSION NUMBER: 0001493152-18-011937 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20180810 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20180815 DATE AS OF CHANGE: 20180814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ProPhase Labs, Inc. CENTRAL INDEX KEY: 0000868278 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232577138 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-21617 FILM NUMBER: 181019531 BUSINESS ADDRESS: STREET 1: 621 N. SHADY RETREAT ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18901 BUSINESS PHONE: 2153450919 MAIL ADDRESS: STREET 1: 621 N. SHADY RETREAT ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18901 FORMER COMPANY: FORMER CONFORMED NAME: QUIGLEY CORP DATE OF NAME CHANGE: 19930328 8-K 1 form8-k.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 10, 2018

 

PROPHASE LABS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   0-21617   23-2577138

(State or other jurisdiction

of incorporation)

 

(Commission

file number)

 

(I.R.S. Employer

Identification No.)

 

621 N. Shady Retreat Road, Doylestown, PA, 18901

(Address of principal executive offices)

 

(Registrant’s telephone number, including area code): (215) 345-0919

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-2)
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. 13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company [  ]                                  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

 

 

   

 

 

Item 2.02 Results of Operations and Financial Condition.

 

On August 14, 2018, ProPhase Labs, Inc. (the “Company”) issued a press release announcing that it will restate its previously issued audited consolidated financial statements for the fiscal year ended December 31, 2017 and unaudited consolidated financial statements for the fiscal quarters ended March 31, 2017, June 30, 2017, September 30, 2017 and March 31, 2018. A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

 

The information in this Item 2.02, including exhibit 99.1 attached hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.

 

On August 10, 2018, the Company’s management, after consultation and discussions with EisnerAmper LLP, the Company’s independent registered public accounting firm, and the Audit Committee of the Board of Directors, concluded that the Company’s previously issued audited consolidated financial statements for the fiscal year ended December 31, 2017 included in the Company’s Annual Report on Form 10-K for such period and unaudited consolidated financial statements for the fiscal quarters ended March 31, 2017, June 30, 2017, September 30, 2017 and March 31, 2018 included in the Company’s Quarterly Reports on Form 10-Q for such periods should no longer be relied upon, and determined that these financial statements will be restated due to the identification of certain accounting errors related to income tax accounting.

 

The Company has determined that it miscalculated its income tax benefit by incorrectly utilizing certain net operating losses without taking into account the statutory limitation imposed by the State of Pennsylvania, which resulted in an overstatement of net income as discussed below. The Company also incorrectly allocated the amount of income tax benefit to continuing operations, which resulted in an overstatement of income from continuing operations, and an equal understatement of the gain on sale of discontinued operations, presented net of taxes, which had no impact on net income.

 

Based on its review, the Company has determined that its income tax expense was understated and its net income was overstated by approximately $1.2 million for the fiscal year ended December 31, 2017. The Company is still in the process of evaluating the impact of this error on its quarterly financial statements for the fiscal quarters ended March 31, 2017, June 30, 2017, September 30, 2017 and March 31, 2018.

 

The Company expects to file an amendment on Form 10-K/A to its Annual Report on Form 10-K for the fiscal year ended December 31, 2017 to restate the audited consolidated financial statements included in the Form 10-K and amendments on Form 10-Q/A to its Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2017, June 30, 2017, September 30, 2017 and March 31, 2018 to correct the errors described above. The Company is seeking to file the amendments on Form 10-K/A and Form 10-Q/A as soon as reasonably practicable.

 

 -2- 

 

 

Accordingly, investors are cautioned not to rely on the Company’s historical financial statements, earnings press releases and similar communications related to these periods. The Company’s management will also reassess its tax provision preparation and review processes and their impact on the Company’s internal controls and will amend, as necessary, any disclosures pertaining to its evaluation of such controls and procedures in connection with its amended Annual Reports on Form 10-K and Quarterly Report on Form 10-Q for the periods described above.

 

Forward-Looking Statements

 

This Current Report on Form 8-K contains forward-looking statements that involve risks and uncertainties, including statements related to the restatements discussed above. In some cases, forward-looking statements can be identified by words such as “anticipates,” “expects,” “believes,” “plans,” “predicts,” and similar terms. Risks, uncertainties and assumptions that could affect the Company’s forward-looking statements include, among other things, risks related to our ability to timely complete the restatements described above, risks that other errors or internal control deficiencies or weaknesses will be identified during our preparation of the restatements and/or risks that additional adjustments will be required. Other risks and uncertainties include, but are not limited to, those discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017 and subsequent Quarterly Reports on Form 10-Q. Unless required by law, the Company expressly disclaims any obligation to update publicly any forward-looking statements, whether as result of new information, future events or otherwise.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

No.   Description
     
99.1   Press Release dated August 14, 2018

 

 -3- 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ProPhase Labs, Inc.
   
  By: /s/ Ted Karkus
    Ted Karkus
    Chairman of the Board, Chief Executive Officer and Director

 

Date: August 14, 2018

 

 -4- 

 

EX-99.1 2 ex99-1.htm

 

Exhibit 99.1

 

 

PROPHASE LABS, INC. ANNOUNCES RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS ARISING FROM $1.2 MILLION UNDERSTATEMENT OF STATE TAXES

 

DOYLESTOWN, PA — (Globe Newswire – August 14, 2018) — ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com), a vertically integrated and diversified branding, marketing and technology company with deep experience in over-the-counter dietary supplements and remedies (“ProPhase” or “Company”), announced today that the Company’s management, after consultation and discussions with EisnerAmper LLP, the Company’s independent registered public accounting firm, and the Audit Committee of the Board of Directors, has determined to restate the Company’s previously issued audited consolidated financial statements for the fiscal year ended December 31, 2017 and unaudited consolidated financial statements for the fiscal quarters ended March 31, 2017, June 30, 2017, September 30, 2017 and March 31, 2018 to correct certain accounting errors related to the Company’s recognition of income tax benefit. In light of these errors, the Company’s previously filed financial statements and other financial information for these periods should no longer be relied upon.

 

The Company has determined that it miscalculated its income tax benefit by incorrectly utilizing certain net operating losses without taking into account the statutory limitation imposed by the State of Pennsylvania, which resulted in an overstatement of net income as discussed below. The Company also incorrectly allocated the amount of income tax benefit to continuing operations, which resulted in an overstatement of income from continuing operations, and an understatement of the gain on sale of discontinued operations, presented net of taxes, which had no impact on net income.

 

Based on its review, the Company has determined that its income tax expense was understated and its net income was overstated by approximately $1.2 million for the fiscal year ended December 31, 2017. Based on its review to date, management anticipates that the restatements will result in a decrease of approximately $16.5 million to income tax benefit from continuing operations and an increase of approximately $15.4 million to gain on sale of discontinued operations, net of taxes. After giving effect to these changes, net income for the fiscal year ended December 31, 2017 is expected to be $40.6 million, or $2.61 per basic share and $2.59 per diluted share of the Company’s common stock, compared with previously reported net income of approximately $41.8 million, or $2.69 per basic share and $2.67 per diluted share of the Company’s common stock.

 

The Company is still in the process of evaluating the impact of this error on its quarterly financial statements for the fiscal quarters ended March 31, 2017, June 30, 2017, September 30, 2017 and March 31, 2018.

 

The Company has determined that the calculation errors described above affect only the periods described in this press release and that the errors have no impact on any prior period results. The Company is not currently aware of any other accounting errors requiring adjustment to any prior period financial statement. However, there can be no assurances that the Company or its independent registered public accounting firm will not find additional accounting errors requiring further adjustment in those or earlier reports.

 

The Company expects to file an amendment on Form 10-K/A to its Annual Report on Form 10-K for the fiscal year ended December 31, 2017 to restate the audited consolidated financial statements included in the Form 10-K and amendments on Form 10-Q/A to its Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2017, June 30, 2017, September 30, 2017 and March 31, 2018 to correct the errors described above. The Company is seeking to file the amendments on Form 10-K/A and Form 10-Q/A as soon as reasonably practicable.

 

 
 

 

About ProPhase Labs

 

ProPhase is a vertically integrated manufacturer, marketer and distributor of a diversified range of over-the-counter (“OTC”) dietary supplements. We are engaged in the research and development of additional OTC dietary supplements, including Legendz XL, which are marketed under our TK Supplements brand. The Company is also developing ProPhase Digital Media as a service that leverages and applies technology to the direct-to-consumer marketing of consumer products. With our enhanced liquidity following the sale of our Cold-EEZE brand, we are also actively exploring additional opportunities outside of the consumer products industry. For more information visit us at www.ProPhaseLabs.com.

 

Forward-Looking Statements

 

All statements contained in this press release, other than statements of historical fact, are forward-looking statements, including statements related to the restatements described above. These statements speak only as of the date of this press release and are based on our current plans and expectations and involve risks and uncertainties that could cause actual future events or results to be different from those described in or implied by such forward-looking statements, including risks and uncertainties relating to our ability to timely complete the restatements, risks that other errors or internal control deficiencies or weaknesses will be identified during our preparation of the restatements and/or risks that additional adjustments will be required. Further information about these matters can be found in our Securities and Exchange Commission filings. Except as required by applicable law or regulation, we do not undertake any obligation to update our forward-looking statements to reflect future events or circumstances.

 

Investor Contact

 

Ted Karkus, Chairman and CEO

ProPhase Labs, Inc.

(267) 880-1111

 

 
 

 

GRAPHIC 3 image_001.jpg begin 644 image_001.jpg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